Population pharmacokinetics of tofacitinib in patients with active ankylosing spondylitis
{{output}}
Objective: To characterize tofacitinib pharmacokinetics (PK) in patients with active ankylosing spondylitis (AS) and estimate the effects of covariates on variability of PK parameters. ... ...
